707 “PROPHYLACTIC” ADEFOVIR “ADD ON” IS ASSSOCIATED WITH A LOWER RATE OF VIROLOGIC BREAKTHROUGH IN PATIENTS WITH OPTIMAL RESPONSE TO LAMIVUDINE AND UNDETECTABLE HBVDNA | Publicación